Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.000
+0.100 (5.26%)
At close: Mar 27, 2026
Market Cap547.05M -39.2%
Revenue (ttm)302.12M +11.5%
Net Income-261.45M
EPS-0.96
Shares Out273.53M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume94,000
Average Volume106,400
Open1.900
Previous Close1.900
Day's Range1.900 - 2.000
52-Week Range1.780 - 4.360
Beta0.25
RSI53.00
Earnings DateMar 30, 2026

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides DA500, a high-throughput gene sequencer that provi... [Read more]

Sector Healthcare
Founded 2010
Employees 419
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2170
Full Company Profile

Financial Performance

In 2024, HKG:2170's revenue was 299.11 million, an increase of 43.82% compared to the previous year's 207.98 million. Losses were -237.03 million, 23.7% more than in 2023.

Financial numbers in CNY Financial Statements